Medicsen

Medicsen is a biomedical company that has developed a needle-free smart patch for the painless delivery of drugs through the skin. This is achieved through the use of sonophoresis, a technology that uses ultrasound waves to temporarily and safely increase the permeability of the skin, allowing for the administration of macromolecular drugs such as insulin.

The company's primary focus is on diabetes management, with the goal of creating a non-invasive artificial pancreas. This system would integrate data from wearable sensors and use predictive AI and algorithms to manage insulin delivery automatically. The smart patch is designed to be an intuitive and user-friendly device.

The company was founded by a team of engineers and doctors, including Dr. Eduardo W. Jorgensen, who serves as the CEO. The team's expertise in both medicine and technology has driven the development of this novel drug delivery system.

Medicsen's business model is centered on the development and commercialization of its smart patch technology. The company targets individuals with chronic diseases, particularly diabetes, who require regular injections. By offering a painless and convenient alternative to traditional needles, Medicsen aims to improve the quality of life for these patients.

The smart patch is a closed-circuit system that combines a wearable sensor, a predictive AI algorithm, and the needle-free drug delivery mechanism. This integrated approach allows for the intelligent and automated management of chronic conditions.

Keywords: needle-free drug delivery, smart patch, ultrasound technology, sonophoresis, diabetes management, non-invasive, artificial pancreas, chronic disease, biomedical, drug delivery system.